What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.70%Below 5Y avg (0.79%)
Annual Rate
CNY 0.20Paid annual
Payout Ratio
29.4%Sustainable
Last Ex-Dividend
Jun 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.83BCNY
574.99M · vs all stocks (USD)
Updated Oct 24, 2026
Trailing P/E
40.07x
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Revenue (TTM)
790.16MCNY
118.51M · vs all stocks (USD)
Updated Oct 24, 2026
Profit Margin
10.76%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Beta
0.4370x
vs all stocks
Updated Oct 24, 2026
52-Week Change
10.27%
vs all stocks
Updated Oct 24, 2026
Market Capitalization
3.83BCNY
574.99M · vs all stocks (USD)
Updated Oct 24, 2026
Enterprise Value
3.22BCNY
483.63M · vs all stocks (USD)
Updated Oct 24, 2026
Trailing P/E
40.07x
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Forward P/E
28.19x
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Price to Sales (TTM)
4.65x
vs Scientific & Technical Instruments peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 4.85×.Updated Oct 24, 2026
Price to Book (MRQ)
4.28x
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Enterprise to Revenue
4.08x
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Enterprise to EBITDA
43.38x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 34.35×.Updated Oct 24, 2026
Gross Margin
51.68%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 47.87%.Updated Oct 24, 2026
Profit Margin
10.76%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Operating Margin
1.29%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Return on Assets (TTM)
2.32%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Return on Equity (TTM)
11.10%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Revenue (TTM)
790.16MCNY
118.51M · vs all stocks (USD)
Updated Oct 24, 2026
Revenue per Share (TTM)
5.86CNYUpdated Oct 24, 2026
Quarterly Revenue Growth
21.60%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Gross Profit (TTM)
378.26MCNY
56.73M · vs all stocks (USD)
Updated Oct 24, 2026
EBITDA (TTM)
93.87MCNY
14.08M · vs all stocks (USD)
Updated Oct 24, 2026
Net Income (TTM)
85.02MCNY
12.75M · vs all stocks (USD)
Updated Oct 24, 2026
Quarterly Earnings Growth (YoY)
188.70%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Operating Cash Flow (TTM)
127.11MCNY
19.06M · vs all stocks (USD)
Updated Oct 24, 2026
Levered Free Cash Flow (TTM)
1.47MCNY
221.02K · vs all stocks (USD)
Updated Oct 24, 2026
Trailing Annual Dividend Rate
0.2000CNYUpdated Oct 24, 2026
Trailing Annual Dividend Yield
0.70%
vs all stocks
Updated Oct 24, 2026
5-Year Average Dividend Yield
0.79%
vs all stocks
Updated Oct 24, 2026
Payout Ratio
29.41%
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Revenue
707.71MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
356.08MCNYFY2025 · Dec 31, 2025
Gross Profit
351.63MCNYFY2025 · Dec 31, 2025
Operating Income
74.07MCNY
11.11M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
55.04MCNYFY2025 · Dec 31, 2025
Income Tax Expense
2.88KCNYFY2025 · Dec 31, 2025
Net Income
55.04MCNYFY2025 · Dec 31, 2025
EBIT
56.93MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
102.71MCNYFY2025 · Dec 31, 2025
Research & Development
124.41MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
65.96MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
7.15MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
758.51KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
1.89MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.4400CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.4400CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
125.09MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
125.09MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
55.04MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
25.96MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-89.89MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
81.29MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
55.04MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
2.04MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
24.96MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-56.09MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-115.85MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-477.08MCNYFY2025 · Dec 31, 2025
Sale of Investments
479.72MCNYFY2025 · Dec 31, 2025
Other Investing Activity
758.51KCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-112.45MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
80.00MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-63.50MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-14.27MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-46.64MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-44.42MCNYFY2025 · Dec 31, 2025
Shares Outstanding
134.71MSharesUpdated Oct 24, 2026
Float Shares
62.39MSharesUpdated Oct 24, 2026
% Held by Insiders
52.79%
vs all stocks
Updated Oct 24, 2026
% Held by Institutions
5.05%
vs all stocks
Updated Oct 24, 2026
Total Cash (MRQ)
238.74MCNY
35.81M · vs all stocks (USD)
Updated Oct 24, 2026
Total Cash per Share (MRQ)
1.91CNYUpdated Oct 24, 2026
Total Debt (MRQ)
48.32MCNY
7.25M · vs all stocks (USD)
Updated Oct 24, 2026
Total Debt to Equity (MRQ)
0.0606x
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Current Ratio (MRQ)
1.96x
vs Scientific & Technical Instruments peers
Updated Oct 24, 2026
Book Value per Share (MRQ)
6.37CNYUpdated Oct 24, 2026
Total Assets
1.32BCNY
197.74M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
908.60MCNYFY2025 · Dec 31, 2025
Total Liabilities
528.00MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
409.82MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
102.64MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
425.36MCNYFY2025 · Dec 31, 2025
Cash
62.15MCNYFY2025 · Dec 31, 2025
Cash Equivalents
19.63MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
81.78MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
203.12MCNYFY2025 · Dec 31, 2025
Accounts Receivable
150.96MCNYFY2025 · Dec 31, 2025
Inventory
305.19MCNYFY2025 · Dec 31, 2025
Accounts Payable
155.70MCNYFY2025 · Dec 31, 2025
Short-term Debt
1.34MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
17.97MCNYFY2025 · Dec 31, 2025
Long-term Debt
47.64MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
134.71MCNYFY2025 · Dec 31, 2025
Retained Earnings
272.20MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
790.42MCNY
118.55M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
151.46MCNYFY2025 · Dec 31, 2025
52-Week Low
19.82CNYUpdated Oct 24, 2026
52-Week High
39.29CNYUpdated Oct 24, 2026
52-Week Change
10.27%
vs all stocks
Updated Oct 24, 2026
Beta
0.4370x
vs all stocks
Updated Oct 24, 2026
50-Day MA
31.72CNYUpdated Oct 24, 2026
200-Day MA
28.25CNYUpdated Oct 24, 2026
Avg 10-Day Volume
2.70MSharesUpdated Oct 24, 2026
Avg 30-Day Volume
5.37MSharesUpdated Oct 24, 2026
Diluted EPS (TTM)
0.6800CNYUpdated Oct 24, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Almost nothing is lost between its operating profit and its net income.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.